The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
CardioGen-82
Rubidium Chloride RB-82 · RUBIDIUM CHLORIDE RB-82 150 mCi/1 · Injection, Solution · Intravenous · Bracco Diagnostics Inc
NDC 00270-0091-01 · 1 INJECTION, SOLUTION in 1 PACKAGE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Is this a "specialty" drug?
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
- Part D specialty tier
- Costs ≥ $950/fill
- Biologic (BLA)
- Injectable / infused
- Orphan-drug exclusivity
- REMS program
Regulatory
- Application
- NDA019414
- TE code
- —
- Approval date
- Dec 29, 1989
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
- Class II · TerminatedJun 1, 2012Bracco Diagnostics Inc — GMP deviation; Sr-82 levels exceeded alert limit specification
Manufacturers of Rubidium Chloride RB-82 (Injection, Solution)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Bracco Diagnostics Inc | RUBIDIUM CHLORIDE RB-82 150 mCi/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "CardioGen-82 — NDC 00270-0091-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00270009101.
Free to cite with attribution — see how the data is put together.